Verition Fund Management LLC Larimar Therapeutics, Inc. Transaction History

Verition Fund Management LLC

$19.9 Billion
Q1 2025

A detailed history of Verition Fund Management LLC transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 567,683 shares of LRMR stock, worth $1.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

567,683

Previous 1,037,748 45.3%

Holding current value

$1.12 Million

Previous $3.96 Million 69.22%

% of portfolio

0.01%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$2.15 - $4.18 $1.01 Million - $1.96 Million	-470,065 Reduced 45.3%	567,683 $1.22 Million
Q4 2024 Feb 14, 2025	SELL	$3.8 - $9.29 $471,207 - $1.15 Million	-124,002 Reduced 10.67%	1,037,748 $3.96 Million
Q3 2024 Nov 14, 2024	SELL	$6.3 - $10.68 $2.72 Million - $4.62 Million	-432,400 Reduced 27.12%	1,161,750 $7.61 Million
Q2 2024 Aug 14, 2024	BUY	$6.33 - $9.89 $585,721 - $915,131	92,531 Added 6.16%	1,594,150 $11.6 Million
Q1 2024 May 14, 2024	SELL	$4.2 - $13.28 $5.5 Million - $17.4 Million	-1,309,512 Reduced 46.58%	1,501,619 $11.4 Million
Q4 2023 Feb 14, 2024	SELL	$2.35 - $4.71 $210,106 - $421,106	-89,407 Reduced 3.08%	2,811,131 $12.8 Million
Q3 2023 Nov 14, 2023	BUY	$3.08 - $4.49 $566,181 - $825,374	183,825 Added 6.77%	2,900,538 $11.5 Million
Q2 2023 Aug 14, 2023	BUY	$3.13 - $5.27 $2.43 Million - $4.1 Million	777,891 Added 40.12%	2,716,713 $8.5 Million
Q1 2023 May 15, 2023	BUY	$4.0 - $6.68 $1.85 Million - $3.09 Million	462,598 Added 31.34%	1,938,822 $8.78 Million
Q4 2022 Feb 14, 2023	BUY	$2.73 - $5.08 $231,744 - $431,231	84,888 Added 6.1%	1,476,224 $6.1 Million
Q3 2022 Nov 14, 2022	BUY	$1.53 - $3.64 $1.51 Million - $3.59 Million	987,446 Added 244.48%	1,391,336 $4.45 Million
Q2 2022 Aug 15, 2022	SELL	$1.9 - $3.98 $39,347 - $82,421	-20,709 Reduced 4.88%	403,890 $792,000
Q1 2022 May 13, 2022	BUY	$3.65 - $10.84 $688,988 - $2.05 Million	188,764 Added 80.04%	424,599 $1.72 Million
Q4 2021 Feb 14, 2022	BUY	$8.86 - $13.47 $1.38 Million - $2.1 Million	156,179 Added 196.07%	235,835 $2.55 Million
Q3 2021 Nov 15, 2021	SELL	$9.61 - $15.11 $1.59 Million - $2.49 Million	-165,019 Reduced 67.44%	79,656 $918,000
Q2 2021 Aug 16, 2021	BUY	$8.0 - $15.2 $122,992 - $233,684	15,374 Added 6.7%	244,675 $2.4 Million
Q1 2021 May 18, 2021	BUY	$14.61 - $22.19 $1.55 Million - $2.36 Million	106,194 Added 86.26%	229,301 $3.35 Million
Q4 2020 Feb 16, 2021	BUY	$14.28 - $25.06 $1.02 Million - $1.78 Million	71,107 Added 136.74%	123,107 $2.64 Million
Q3 2020 Nov 16, 2020	BUY	$10.5 - $17.6 $546,000 - $915,200	52,000 New	52,000 $789,000

Others Institutions Holding LRMR

# of Institutions

108

Shares Held

64.5M

Call Options Held

93.5K

Put Options Held

68K

View Full List

About Larimar Therapeutics, Inc.

Ticker LRMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,269,200
Market Cap $85.7M
Description
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...

More about LRMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Larimar Therapeutics, Inc. Transaction History